May 12, 2020
Kaléo Announces ALLERJECT® (epinephrine injection, USP) Auto-Injector Will Be Available for Canadians at Risk for Anaphylaxis Starting May 19, 2020
Apr 27, 2020
Mesa Science Associates and Bryn Pharma Publish Second Pre-Clinical Study of a New Approach to Treating Anaphylaxis
Apr 24, 2020
The epinephrine auto-injector market is expected to grow at a CAGR of over 8% during the period 2019-2025
Apr 23, 2020
The Global Epinephrine Auto-injector Market to Reach Revenues of Over $2 Billion During the Period 2020 -2025 - Market Research by Arizton
Apr 06, 2020
Bryn Pharma Presents Data Demonstrating Comparable Pharmacokinetic and Pharmacodynamic Effects of Intranasal Epinephrine to Intramuscular Epinephrine in Adults
Mar 17, 2020
Epinephrine Nasal Spray Demonstrates Bioequivalent Exposure and Absorption Rate Compared to Epinephrine Injectors
Feb 12, 2020
E.A.T Announces Winners of $1 Million Grand Challenge to End Anaphylaxis
Oct 29, 2019
Bryn Pharma Presents Data Demonstrating Patient Preference for Bi-dose Epinephrine Nasal Spray over EpiPen®
Oct 10, 2019
Bryn Pharma Completes Dosing in Pivotal Clinical Trial Designed to Support U.S. Approval of Intranasal Epinephrine Spray
Jun 11, 2019
Stocking Epinephrine Auto-Injectors on Commercial Flights Found to be Cost-Effective
May 06, 2019
European Commission Approves Palynziq® (pegvaliase injection) for Treatment of Phenylketonuria (PKU) in Patients Aged 16 Years or Older
Mar 01, 2019
BioMarin Receives Positive CHMP Opinion in Europe for Palynziq® (pegvaliase Injection) for Treatment of Patients with Phenylketonuria (PKU) Aged 16 and Older
Jan 15, 2019
StellaPharma to Develop Epinephrine Nasal Spray Product
Sep 28, 2018
Advisory - EpiPen and EpiPen Jr auto-injectors may stick in their carrier tube
Apr 26, 2018
With Life-Threatening Allergies Diagnosed in Infancy, kaléo Announces Availability of First and Only FDA-Approved Epinephrine Auto-Injector (EAI) for Infants and Toddlers Weighing 16.5 to 33 Pounds (7.5 to 15 kilograms)
Apr 23, 2018
Elusys Receives Second Delivery Order From U.S. Government for ANTHIM®, its Treatment for Inhalation Anthrax
Jan 18, 2018
Information Update - Shortage of EpiPen (0.3 mg) auto-injector in Canada
Nov 20, 2017
U.S. FDA Approves Kaléo's AUVI-Q® (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children
Oct 27, 2017
Mylan's EpiPen4Schools® Program Surpasses One Million Free Epinephrine Auto-Injector Donations to U.S. Schools
Jul 27, 2017
U.S. FDA Grants Priority Review for an Epinephrine Auto-Injector in Development by Kaléo Specifically for Infants and Small Children